Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | J9051 |
| Short Description | Inj, bortezomib (maia) |
| Long Description | Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
| Pricing indicator | 51 |
| Coverage code | C |
| ASC payment group code | |
| BETOS2 code | O1D |
| Action code | N |
| Type of service | 1 |
| Effective date | 2023-10-01 |
| Date Added | 2023-10-01 |
Drug Details
-
Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.